CALL FOR PROPOSALS
On behalf of Stand Up To Cancer (SU2C) and the Dutch Cancer Society - KWF Kankerbesrtijding (KWF), the American Association for Cancer Research (AACR) is accepting applications for a Sta Op Tegen Kanker Dream Team Translational Cancer Research Grant that will offer up to €6 million in research funding.
The grant provides four years of funding for a translational cancer research project that will address critical problems in patient care and deliver near-term patient benefit through investigation by a multidisciplinary, multi-institutional team of expert investigators. Research projects must be designed to accelerate the application of new preventive, diagnostic or therapeutic agents to the clinic, and may focus on particular organ sites or on specialized research areas.
Proposals for the Sta Op Tegen Kanker Dream Team Translational Cancer Research Grant must describe plans indicating how the work will be translated into the clinic. To maximize creativity, innovation and collaboration, the projects should span multiple disciplines and use modern biological tools to attack research questions in a coordinated way.
April 10, 2013, at 12 p.m. (noon) ET
Applications must be submitted online using the proposalCENTRAL website
START OF GRANT TERM
Jan. 1, 2014
The Dream Team leader must be from a research institute located in the Netherlands. Dream Team co-leader (optional) and principals can be from research institutes in any country. Each project must include at least two research institutes located in the Netherlands and at least one research institute outside the Netherlands. At least 50 percent of the grant funds must be allocated to research conducted in the Netherlands.
Employees or subcontractors of a for-profit industry are not eligible to apply as leader, co-leader, principals or investigators, but may be listed as collaborators. No grant funds may be directed to collaborators working within government institutions or for-profit industry.
Complete Program Guidelines and Submission Instructions are available below and on the proposalCENTRAL website.
Program Guidelines (Adobe Acrobat Reader is required)
Telephone: (267) 765-1049
Fax: (267) 765-1046
Since its launch in 2008, Stand Up To Cancer (SU2C) has funded a total of nine Dream Teams, one International Translational Cancer Research Team and 26 Innovative Research Grants, totaling more than $130 million. These grants encompass more than 450 scientists from 87 institutions conducting more than 30 clinical trials.
On May 28, 2009, one year after its launch, SU2C announced funding of five multi-institutional, cross-disciplinary, three-year “Dream Team” grants, totaling $73.6 million. Since then, SU2C has partnered with other renowned organizations to jointly fund Dream Teams focusing on specific areas of cancer research. In December 2011, SU2C and the Melanoma Research Alliance announced a new Dream Team that will receive $6 million over three years for translational research focusing on melanoma. In 2012, three new Dream Teams were announced focusing on prostate cancer (two Dream Teams in collaboration with the Prostate Cancer Foundation), and cancer immunology (one Dream Team in collaboration with the Cancer Research Institute). Each jointly funded grant will provide $10 million over three years for a total of $30 million.
In addition, on August 2, 2012, SU2C, in collaboration with Kankerbestrijding/The Dutch Cancer Society (KWF), announced recipients of a new Sta Op Tegen Kanker International Translational Cancer Research Grant. This grant provides funding of €1.2 million ($1.3 million U.S.) for four years. The funding mechanism represents a new, focused effort to affect advances in cancer research as rapidly as possible through the creation of collaborative, international translational cancer research “Team.”
Finally, through its Innovative Research Grants, SU2C has made an effort to support the next generation of extraordinary leaders in their quest to conquer cancer. These grants provide up to $750,000, over a three-year term, to early-career scientists whose novel, high-risk, high-reward research proposals may have significant potential for translational application. Thirteen grants were awarded in 2009, and 13 more in 2011 totaling $19.4 million.
Updated: Jan. 15, 2013